论文部分内容阅读
日本大学医学部妇产科不孕症门诊于1982年起两年间,对就诊的650例不孕症的原因进行分析,其中子宫卵管因素占37.7%,居第一位;其次是排卵障碍,占34%;余28.3%为男性不孕症。对卵管性不孕症的治疗用体外授精-胚移植(IVF-ET)以及显微手术卵管形成术(MS)。IVF-ET 是划时代建立起的治疗方法,至今日本已有40例以上的体外受精儿出生,今后将会更多。关于卵管性不孕症的治疗,IVF-ET 和 MS 二者哪一种应为首选,尚无统一见解。本教研组对卵管性不孕症的治疗方针
Nihon University Faculty of Medicine, Department of Obstetrics and Gynecology infertility clinic in 1982 two years, the treatment of 650 cases of infertility were analyzed, of which 37.7% uterine and ovarian factors, ranking first; followed by ovulation disorders, accounting for 34%; the remaining 28.3% male infertility. IVF-ET and microsurgical ovoplasty (MS) were used to treat tubal infertility. IVF-ET is an epoch-making treatment, so far more than 40 in vitro fertilization children have been born in Japan and will be more in the future. On the treatment of tubal infertility, which of IVF-ET and MS should be the first choice, there is no uniform opinion. The teaching and research group of tubal infertility treatment guidelines